giredestrant,amcenestrant,sar439859
sanofi,roche
['ameera 3', 'acelera', 'amcenestrant', 'giredestrant']
oral serds #esmo2022 and miguel martin present late line ameera 3 and acelera trials. both amcenestrant and giredestrant were not better that et of choice but +signal in esr1 mutant disease. selection/biology key in late line studies. 